Progress and Challenge of Cardiac Regeneration to Treat Heart Failure

Journal of Cardiology

Volumn 73, Issue 2, 2019, Pages 97-101

  Isomi, Mari ^a   Sadahiro, Taketaro ^a   Ieda, Masaki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Direct reprogramming; Fibroblasts; Regeneration

Indexed keywords

CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CELL PROLIFERATION; CELL REGENERATION; CELL THERAPY; EPIGENETICS; HEART FAILURE; HEART FIBROBLAST; HUMAN; IN VIVO STUDY; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL; ANIMAL; CARDIAC MUSCLE; CELL DIFFERENTIATION; FIBROBLAST; HEART; HEART INFARCTION; INDUCED PLURIPOTENT STEM CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; FIBROBLASTS; GUIDED TISSUE REGENERATION; HEART; HEART FAILURE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 85056211685     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2018.10.002     Document Type: Review

References (29)

1. Porrello, E.R., Mahmoud, A.I., Simpson, E., Hill, J.A., Richardson, J.A., Olson, E.N., et al. Transient regenerative potential of the neonatal mouse heart. Science 331 (2011), 1078–1080.
2. Bergmann, O., Bhardwaj, R.D., Bernard, S., Zdunek, S., Barnabe-Heider, F., Walsh, S., et al. Evidence for cardiomyocyte renewal in humans. Science 324 (2009), 98–102.
3. Behfar, A., Crespo-Diaz, R., Terzic, A., Gersh, B.J., Cell therapy for cardiac repair – lessons from clinical trials. Nat Rev Cardiol 11 (2014), 232–246.
4. Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003), 763–776.
5. Makkar, R.R., Smith, R.R., Cheng, K., Malliaras, K., Thomson, L.E., Berman, D., et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379 (2012), 895–904.
6. Hare, J.M., Fishman, J.E., Gerstenblith, G., DiFede Velazquez, D.L., Zambrano, J.P., Suncion, V.Y., et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 308 (2012), 2369–2379.
7. Dixon, J.A., Gorman, R.C., Stroud, R.E., Bouges, S., Hirotsugu, H., Gorman, J.H. 3rd, et al. Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation 120 (2009), S220–S229.
8. Bolli, R., Tang, X.L., Sanganalmath, S.K., Rimoldi, O., Mosna, F., Abdel-Latif, A., et al. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 128 (2013), 122–131.
9. Bolli, R., Chugh, A.R., D'Amario, D., Loughran, J.H., Stoddard, M.F., Ikram, S., et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378 (2011), 1847–1857.
10. van Berlo, J.H., Kanisicak, O., Maillet, M., Vagnozzi, R.J., Karch, J., Lin, S.C., et al. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509 (2014), 337–341.
11. Kawamura, M., Miyagawa, S., Miki, K., Saito, A., Fukushima, S., Higuchi, T., et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126 (2012), S29–S37.
12. Qiao, H., Zhang, H., Yamanaka, S., Patel, V.V., Petrenko, N.B., Huang, B., et al. Long-term improvement in postinfarct left ventricular global and regional contractile function is mediated by embryonic stem cell-derived cardiomyocytes. Circ Cardiovasc Imaging 4 (2011), 33–41.
13. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007), 861–872.
14. Shiba, Y., Gomibuchi, T., Seto, T., Wada, Y., Ichimura, H., Tanaka, Y., et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538 (2016), 388–391.
15. Tohyama, S., Hattori, F., Sano, M., Hishiki, T., Nagahata, Y., Matsuura, T., et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12 (2013), 127–137.
16. Mohamed, T.M.A., Ang, Y.S., Radzinsky, E., Zhou, P., Huang, Y., Elfenbein, A., et al. Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell, 173, 2018 104–16 e12.
17. Tao, G., Kahr, P.C., Morikawa, Y., Zhang, M., Rahmani, M., Heallen, T.R., et al. Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury. Nature 534 (2016), 119–123.
18. Nakada, Y., Canseco, D.C., Thet, S., Abdisalaam, S., Asaithamby, A., Santos, C.X., et al. Hypoxia induces heart regeneration in adult mice. Nature 541 (2017), 222–227.
19. Ieda, M., Fu, J.D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B.G., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142 (2010), 375–386.
20. Nam, Y.J., Song, K., Luo, X., Daniel, E., Lambeth, K., West, K., et al. Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci U S A 110 (2013), 5588–5593.
21. Wada, R., Muraoka, N., Inagawa, K., Yamakawa, H., Miyamoto, K., Sadahiro, T., et al. Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc Natl Acad Sci U S A 110 (2013), 12667–12672.
22. Cao, N., Huang, Y., Zheng, J., Spencer, C.I., Zhang, Y., Fu, J.D., et al. Conversion of human fibroblasts into functional cardiomyocytes by small molecules. Science 352 (2016), 1216–1220.
23. Ifkovits, J.L., Addis, R.C., Epstein, J.A., Gearhart, J.D., Inhibition of TGFbeta signaling increases direct conversion of fibroblasts to induced cardiomyocytes. PLoS ONE, 9, 2014, e89678.
24. Mohamed, T.M., Stone, N.R., Berry, E.C., Radzinsky, E., Huang, Y., Pratt, K., et al. Chemical enhancement of in vitro and in vivo direct cardiac reprogramming. Circulation 135 (2017), 978–995.
25. Zhou, Y., Wang, L., Vaseghi, H.R., Liu, Z., Lu, R., Alimohamadi, S., et al. Bmi1 is a key epigenetic barrier to direct cardiac reprogramming. Cell Stem Cell 18 (2016), 382–395.
26. Qian, L., Huang, Y., Spencer, C.I., Foley, A., Vedantham, V., Liu, L., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485 (2012), 593–598.
27. Song, K., Nam, Y.J., Luo, X., Qi, X., Tan, W., Huang, G.N., et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485 (2012), 599–604.
28. Jayawardena, T.M., Finch, E.A., Zhang, L., Zhang, H., Hodgkinson, C., Pratt, R.E., et al. MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. Circ Res 116 (2015), 418–424.
29. Miyamoto, K., Akiyama, M., Tamura, F., Isomi, M., Yamakawa, H., Sadahiro, T., et al. Direct in vivo reprogramming with Sendai virus vectors improves cardiac function after myocardial infarction. Cell Stem Cell, 22, 2018 91–103 e5.